Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sputnik Light Phase 3 COVID-19 Vaccine Study
NCT04741061Phase 3Unknown
- Start
- Feb 2021
- Primary completion
- Dec 2021
- Modality
- Viral Vectors, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Sputnik Light Vaccine with Placebo Group (2 arms). Primary endpoints: Incidence and severity of adverse events at 180 days and Percentage of study subjects with COVID-19 cases developed after vaccination at 180 days. Status: unknown.
02
Drugs
rAd26
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04741061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04741061.